Pamela Tabar was editor-in-chief of I Advance Senior Care from 2013-2018. She has worked as a writer and editor for healthcare business media since 1998, including as News Editor of Healthcare Informatics. She has a master’s degree in journalism from Kent State University and a master's degree in English from the University of York, England.
Much like the Nursing Home Compare site for skilled nursing facilities, the new data comparison tool will allow consumers to see quality measures data on hospice and palliative care providers. Read More »
I Advance Senior Care is proud to announce the winners of the 2017 OPTIMA Award for Excellence in Resident-Focused Care and this year’s new award, the OPTIMA Award for Excellence in Memory Care. Read More »
Despite 21 Top 40 hits, dozens of albums and several appearances on the silver screen, the music legend may end up being best known for his brave and open approach to his own disease. Read More »
The video-based training will help administrators provide sensitivity training and education on fighting the stereotypes and assumptions about older adults and the aging process. Read More »
The national memory care provider is building its fifth site in the Chicago area—this time, a 47,000 sq. ft. community that will serve up to 90 residents with dementia. Read More »
Many surgery patients seem to have plenty of prescription pain pills left over after their recovery, and that’s a big problem, says a new JAMA study. Read More »
Sleep-disordered breathing may affect cognition, especially in those who carry the APOE-4 gene, thought to be a genetic risk factor for Alzheimer's. Read More »
The Senate has voted 51-49 to keep the Affordable Care Act law the way it is—for now. Majority Leader Mitch McConnell says it’s time to “move on.” Read More »
July has been a record-breaking month for the Department of Justice’s fraud squad, which orchestrated a 30-state takedown totaling $1.3 billion in fraudulent or illegal activities. Read More »
A medication for type 2 diabetes called metformin is the subject of a study exploring the possible effects of the drug on the development of dementia. Read More »